AstraZeneca CEO Pascal Soriot is not overly concerned about the threat of tariffs by the Trump administration on ...

Pioneering a first-in-class drug-targeting approach that leverages hormone analogues to deliver small-molecule neuroplasticity modulators directly to the brain's appetite control centersFinancing ...

AstraZeneca's three-drug inhaler Breztri Aerosphere has shown efficacy for uncontrolled asthma in a pair of phase 3 trials ...

A day of expert panels and prestigious honours for the UK's most impactful health innovations LONDON, May 8, 2025 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated ...

AstraZeneca PLC closed 23.51% short of its 52-week high of £133.88, which the company achieved on September 3rd.

AstraZeneca PLC closed 24.31% short of its 52-week high of £133.88, which the company reached on September 3rd.

For what brand would not want its logo to be emphasized? And if a company’s goal is to use its logo to communicate boldness as a brand attribute, the single most obvious, literal, no-brainer way ...

AstraZeneca expects only limited impact from potential U.S. tariffs on pharmaceutical imports, the drugmaker said ...

May 2 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Friday its triple-combination inhaler Breztri Aerosphere met all main goals in two late-stage trials for uncontrolled asthma ...

London: British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production ...

AstraZeneca earned more than $1.4 billion from sales of the drug in the first half of 2024, according to a company report. EmblemHealth said in the lawsuit that AstraZeneca charges "one of the ...